Thermo Fisher Scientific Derivative Liabilities - Fair Value increased by 39.2% to $444.00M in Q1 2026 compared to the prior quarter. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase in liabilities suggests unfavorable market movements for the company's hedges, while a decrease indicates a reduction in potential settlement obligations.
This represents the fair value of derivative financial instruments that are currently in a liability position. These lia...
Standard for energy companies; peers with similar hedging profiles will show comparable volatility in this line item.
derivative_liabilities_fair_value| Q4 '25 | Q1 '26 | |
|---|---|---|
| Value | $319.00M | $444.00M |
| QoQ Change | — | +39.2% |